HCPCS drug code · CMS crosswalk
Gemcitabine J-Code / HCPCS Code
In short
Gemcitabine is billed under HCPCS J9201 — Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg. One billing unit is 200 mg. CMS's crosswalk lists 31 Gemcitabine NDCs under this code.
Reference
- J9201
- Injection, gemcitabine hydrochloride, not otherwise specified, 200 mgBilling unit: 200 mg
- Labelers
- Athenex Pharmaceutical Division, LLC; FreseniUS Kabi USA, LLC; Hikma Pharmaceuticals USA Inc.; Meitheal Pharmaceuticals Inc.; Mylan Institutional LLC; Northstar RxLLC; Pfizer Inc; Sagent Pharmaceuticals
Medicare Part B payment limit
CMS ASP fileEffective October 1, 2026 through December 31, 2026. Payment allowance limits subject to the ASP methodology are based on 2Q26 ASP data. A payment limit is not a coverage decision; the Medicare contractor decides coverage. CMS ASP pricing files
Gemcitabine units and claim line
Enter the dose given to get the J9201 units and the NDC line for the CMS-1500 and the 837P.
Enter the dose given to build the claim line.
Gemcitabine NDCs and billing units
From CMS’s ASP NDC–HCPCS crosswalk, effective October 1, 2026 through December 31, 2026. Billing units per package are CMS’s figures for the code’s unit.
| NDC (11-digit) | HCPCS | Labeler | Package | Billing units per package |
|---|---|---|---|---|
| 00143-9340-01 | J9201 | Hikma Pharmaceuticals USA Inc. | 5.26 | 1 |
| 00143-9341-01 | J9201 | Hikma Pharmaceuticals USA Inc. | 26.3 | 5 |
| 00143-9342-01 | J9201 | Hikma Pharmaceuticals USA Inc. | 52.6 | 10 |
| 00409-0181-01 | J9201 | Pfizer Inc | 26.3 | 5 |
| 00409-0181-25 | J9201 | Pfizer Inc | 26.3 | 5 |
| 00409-0182-01 | J9201 | Pfizer Inc | 52.6 | 10 |
| 00409-0182-25 | J9201 | Pfizer Inc | 52.6 | 10 |
| 00409-0183-01 | J9201 | Pfizer Inc | 5.26 | 1 |
| 00409-0183-25 | J9201 | Pfizer Inc | 5.26 | 1 |
| 00409-0185-01 | J9201 | Pfizer Inc | 1 | 1 |
| 00409-0186-01 | J9201 | Pfizer Inc | 1 | 5 |
| 00409-0187-01 | J9201 | Pfizer Inc | 1 | 10 |
| 16714-0909-01 | J9201 | Northstar RxLLC | 1 | 1 |
| 16714-0930-01 | J9201 | Northstar RxLLC | 1 | 5 |
| 25021-0234-10 | J9201 | Sagent Pharmaceuticals | 1 | 1 |
| 25021-0235-50 | J9201 | Sagent Pharmaceuticals | 1 | 5 |
| 25021-0235-51 | J9201 | Sagent Pharmaceuticals | 10 × 1 | 50 |
| 25021-0239-05 | J9201 | Sagent Pharmaceuticals | 5.26 | 1 |
| 25021-0239-26 | J9201 | Sagent Pharmaceuticals | 26.3 | 5 |
| 25021-0239-52 | J9201 | Sagent Pharmaceuticals | 52.6 | 10 |
| 63323-0102-13 | J9201 | FreseniUS Kabi USA, LLC | 1 | 1 |
| 63323-0125-53 | J9201 | FreseniUS Kabi USA, LLC | 1 | 5 |
| 67457-0616-10 | J9201 | Mylan Institutional LLC | 5.26 | 1 |
| 67457-0617-30 | J9201 | Mylan Institutional LLC | 26.3 | 5 |
| 67457-0618-10 | J9201 | Mylan Institutional LLC | 52.6 | 10 |
| 70860-0205-50 | J9201 | Athenex Pharmaceutical Division, LLC | 1 | 5 |
| 71288-0113-10 | J9201 | Meitheal Pharmaceuticals Inc. | 1 | 1 |
| 71288-0114-50 | J9201 | Meitheal Pharmaceuticals Inc. | 1 | 5 |
| 71288-0117-06 | J9201 | Meitheal Pharmaceuticals Inc. | 5.26 | 1 |
| 71288-0117-28 | J9201 | Meitheal Pharmaceuticals Inc. | 26.3 | 5 |
| 71288-0117-54 | J9201 | Meitheal Pharmaceuticals Inc. | 52.6 | 10 |
Gemcitabine: common questions
- What is the J-code for Gemcitabine?
- Gemcitabine is billed under HCPCS J9201 — Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg. One billing unit is 200 mg. CMS's crosswalk lists 31 Gemcitabine NDCs under this code.
- How many J9201 billing units are in a package of Gemcitabine?
- CMS lists 1 to 50 billing units per package, depending on the NDC, where one unit is 200 mg. Units to report are based on the dose given, not the package.
- Is J9201 a CPT code?
- No. J9201 is a HCPCS Level II code from CMS for the drug itself. Giving it, for example by injection or infusion, is usually reported with a separate CPT administration code.